669 related articles for article (PubMed ID: 16253930)
1. Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes.
Antzelevitch C
Heart Rhythm; 2005 Nov; 2(2 Suppl):S9-15. PubMed ID: 16253930
[TBL] [Abstract][Full Text] [Related]
2. Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes.
Antzelevitch C
Europace; 2007 Sep; 9 Suppl 4(Suppl 4):iv4-15. PubMed ID: 17766323
[TBL] [Abstract][Full Text] [Related]
3. Arrhythmogenic mechanisms of QT prolonging drugs: is QT prolongation really the problem?
Antzelevitch C
J Electrocardiol; 2004; 37 Suppl():15-24. PubMed ID: 15534788
[TBL] [Abstract][Full Text] [Related]
4. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome.
Antzelevitch C; Yan GX; Shimizu W
J Electrocardiol; 1999; 32 Suppl():158-65. PubMed ID: 10688320
[TBL] [Abstract][Full Text] [Related]
5. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
6. Cellular mechanisms underlying the long QT syndrome.
Antzelevitch C; Shimizu W
Curr Opin Cardiol; 2002 Jan; 17(1):43-51. PubMed ID: 11790933
[TBL] [Abstract][Full Text] [Related]
7. Cellular basis for QT dispersion.
Antzelevitch C; Shimizu W; Yan GX; Sicouri S
J Electrocardiol; 1998; 30 Suppl():168-75. PubMed ID: 9535495
[TBL] [Abstract][Full Text] [Related]
8. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes.
Antzelevitch C; Sun ZQ; Zhang ZQ; Yan GX
J Am Coll Cardiol; 1996 Dec; 28(7):1836-48. PubMed ID: 8962574
[TBL] [Abstract][Full Text] [Related]
9. Cisapride-induced transmural dispersion of repolarization and torsade de pointes in the canine left ventricular wedge preparation during epicardial stimulation.
Di Diego JM; Belardinelli L; Antzelevitch C
Circulation; 2003 Aug; 108(8):1027-33. PubMed ID: 12912819
[TBL] [Abstract][Full Text] [Related]
10. Transmural heterogeneity of ventricular repolarization under baseline and long QT conditions in the canine heart in vivo: torsades de pointes develops with halothane but not pentobarbital anesthesia.
Weissenburger J; Nesterenko VV; Antzelevitch C
J Cardiovasc Electrophysiol; 2000 Mar; 11(3):290-304. PubMed ID: 10749352
[TBL] [Abstract][Full Text] [Related]
11. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes?
Medina-Ravell VA; Lankipalli RS; Yan GX; Antzelevitch C; Medina-Malpica NA; Medina-Malpica OA; Droogan C; Kowey PR
Circulation; 2003 Feb; 107(5):740-6. PubMed ID: 12578878
[TBL] [Abstract][Full Text] [Related]
12. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes.
Shimizu W; Antzelevitch C
Circulation; 1998 Nov; 98(21):2314-22. PubMed ID: 9826320
[TBL] [Abstract][Full Text] [Related]
13. Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsades de Pointes in models of acquired and congenital long QT syndrome.
Shimizu W; McMahon B; Antzelevitch C
J Cardiovasc Electrophysiol; 1999 Feb; 10(2):154-64. PubMed ID: 10090218
[TBL] [Abstract][Full Text] [Related]
14. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome.
Shimizu W; Antzelevitch C
Circulation; 1997 Sep; 96(6):2038-47. PubMed ID: 9323097
[TBL] [Abstract][Full Text] [Related]
15. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
Hii JT; Wyse DG; Gillis AM; Duff HJ; Solylo MA; Mitchell LB
Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949
[TBL] [Abstract][Full Text] [Related]
16. Epicardial activation of left ventricular wall prolongs QT interval and transmural dispersion of repolarization: implications for biventricular pacing.
Fish JM; Di Diego JM; Nesterenko V; Antzelevitch C
Circulation; 2004 May; 109(17):2136-42. PubMed ID: 15078801
[TBL] [Abstract][Full Text] [Related]
17. Use of preclinical assays to predict risk of drug-induced torsades de pointes.
Belardinelli L; Shryock JC; Wu L; Song Y
Heart Rhythm; 2005 Nov; 2(2 Suppl):S16-22. PubMed ID: 16253927
[TBL] [Abstract][Full Text] [Related]
18. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome.
Yan GX; Antzelevitch C
Circulation; 1998 Nov; 98(18):1928-36. PubMed ID: 9799215
[TBL] [Abstract][Full Text] [Related]
19. Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine.
Sicouri S; Timothy KW; Zygmunt AC; Glass A; Goodrow RJ; Belardinelli L; Antzelevitch C
Heart Rhythm; 2007 May; 4(5):638-47. PubMed ID: 17467634
[TBL] [Abstract][Full Text] [Related]
20. Transmural dispersion of repolarization as a preclinical marker of drug-induced proarrhythmia.
Said TH; Wilson LD; Jeyaraj D; Fossa AA; Rosenbaum DS
J Cardiovasc Pharmacol; 2012 Aug; 60(2):165-71. PubMed ID: 22561361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
